Cargando…

Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights

Immune checkpoints limit the activation of the immune system and serve an important homeostatic function but can also restrict immune responses against tumors. Inhibition of specific immune checkpoint proteins such as the B7:CD28 family members programmed cell death protein-1 (PD-1) and cytotoxic T-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noelle, Randolph J., Lines, J. Louise, Lewis, Lionel D., Martell, Robert E., Guillaudeux, Thierry, Lee, Sam W., Mahoney, Kathleen M., Vesely, Matthew D., Boyd-Kirkup, Jerome, Nambiar, Dhanya K., Scott, Andrew M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547146/ https://www.ncbi.nlm.nih.gov/pubmed/37795437 http://dx.doi.org/10.3389/fonc.2023.1225081

Ejemplares similares

Exploring the VISTA of microglia: immune checkpoints in CNS inflammation
por: Borggrewe, Malte, et al.
Publicado: (2020)

VISTA expression and patient selection for immune-based anticancer therapy
por: Martin, Alexander S., et al.
Publicado: (2023)

A New VISTA on combination therapy for negative checkpoint regulator blockade
por: Deng, Jie, et al.
Publicado: (2016)

Enhancement of Radiation Therapy through Blockade of the Immune Checkpoint, V-domain Ig Suppressor of T Cell Activation (VISTA), in Melanoma and Adenocarcinoma Murine Models
por: Duval, Kayla E. A., et al.
Publicado: (2023)

Defining the Signature of VISTA on Myeloid Cell Chemokine Responsiveness
por: Broughton, Thomas W. K., et al.
Publicado: (2019)

Beyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint Regulators
por: Le Mercier, Isabelle, et al.
Publicado: (2015)

VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
por: Wang, Li, et al.
Publicado: (2011)

Immuno-Oncology 360° 8th Annual Event Highlights
por: McCarthy, Danny
Publicado: (2022)

Analysis of VISTA expression and function in renal cell carcinoma highlights VISTA as a potential target for immunotherapy
por: Hong, Shanjuan, et al.
Publicado: (2019)

VISTA: A Target to Manage the Innate Cytokine Storm
por: ElTanbouly, Mohamed A., et al.
Publicado: (2021)

Rationally targeted anti-VISTA antibody that blockades the C-C’ loop region can reverse VISTA immune suppression and remodel the immune microenvironment to potently inhibit tumor growth in an Fc independent manner
por: Thakkar, Dipti, et al.
Publicado: (2022)

VISTA expression by microglia decreases during inflammation and is differentially regulated in CNS diseases
por: Borggrewe, Malte, et al.
Publicado: (2018)

Some Shakespearean themes ; and An approach to 'Hamlet' /
por: Knights, Lionel Charles, 1906-
Publicado: (1966)

Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer
por: Hou, Zelin, et al.
Publicado: (2020)

The immune checkpoint VISTA is associated with prognosis in patients with malignant uveal melanoma
por: Issam Salah, Nour el Imane, et al.
Publicado: (2023)

Immune-checkpoint protein VISTA in allergic, autoimmune disease and transplant rejection
por: Zheng, Meijun, et al.
Publicado: (2023)

Immuno-Oncology
por: Chaudhuri, Swapna
Publicado: (2017)

Immune checkpoint inhibitor-related hypogonadism and infertility: a neglected issue in immuno-oncology
por: Özdemir, Berna C
Publicado: (2021)

Immune checkpoint inhibitors break whose heart? Perspectives from cardio-immuno-oncology
por: He, Yingying, et al.
Publicado: (2023)

Identification of active small-molecule modulators targeting the novel immune checkpoint VISTA
por: Li, Ting-ting, et al.
Publicado: (2021)

IGSF11 and VISTA: a pair of promising immune checkpoints in tumor immunotherapy
por: Tang, Xi-Yang, et al.
Publicado: (2022)

VISTA regulates microglia homeostasis and myelin phagocytosis, and is associated with MS lesion pathology
por: Borggrewe, Malte, et al.
Publicado: (2021)

VISTA Re-programs Macrophage Biology Through the Combined Regulation of Tolerance and Anti-inflammatory Pathways
por: ElTanbouly, Mohamed A., et al.
Publicado: (2020)

VISTA: A Mediator of Quiescence and a Promising Target in Cancer Immunotherapy
por: Yuan, Long, et al.
Publicado: (2021)

Presentation of themes by Theme Coordinators
por: Ioannis Baltopoulos, Gerhard Brandt, Brice Copy, Zornitsa Zaharieva
Publicado: (2005)

The Expression Pattern and Clinical Significance of the Immune Checkpoint Regulator VISTA in Human Breast Cancer
por: Xie, Xiaoxue, et al.
Publicado: (2020)

Immuno‐Oncology in China
por: Lu, Shun, et al.
Publicado: (2019)

Radiomics in immuno-oncology
por: Bodalal, Z., et al.
Publicado: (2021)

Vistas in astronomy
por: Beer, Arthur
Publicado: (1968)

Vistas in astronomy
por: Beer, Arthur
Publicado: (1969)

Vistas in astronomy
por: Beer, Arthur
Publicado: (1960)

Vistas in nanofabrication
por: Rahman, Faiz
Publicado: (2013)

Vistas in astronomy
por: Beer, Arthur
Publicado: (1972)

Vistas of China
Publicado: (1987)

Vistas in astronomy
por: Beer, Arthur
Publicado: (1974)

Vistas in Nanofabrication
por: Rahman, Faiz
Publicado: (2012)

VISTA Trials
por: Gilotay, Caroline, et al.
Publicado: (2015)

Vistas for the future
por: Grewal, Anju
Publicado: (2015)

VISTAS of the Future
por: Basu, Ashoke Kumar
Publicado: (2019)

Gene expression profiles (GEPs) of immuno-oncologic pathways as predictors of response to checkpoint inhibitors in advanced NSCLC
por: De Marchi, Pedro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e0c2prevfjafqkku2roj4sp1u2